Clinical trial participation among underserved communities: Insights from the Louisiana Community Engagement Alliance
Description
CONCLUSION: COVID-19 trial participation rates were low in our sample. Altruism was a key facilitator to participation; fear, mistrust, and low awareness were predominant barriers. Community-centered approaches, engaging informed providers and
